NRG BR008 (XRT at MBMC Only)

Study Number: NRG BR008 (XRT at MBMC Only)

Please Note:

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.

Available Sites

• Missouri Baptist Medical Center
• Missouri Baptist Sullivan Hospital
• Missouri Baptist Medical Center
• Sainte Genevieve County Memorial Hospital
• Parkland Health Center - Farmington

Contact Person(s)

• Opal Potter 314-996-5865

View More Information - This link will take you to clinicaltrials.gov for specific study information including eligibility criteria. A full list of participating institutions can also be found on this page.